Clinical Trials for: mupirocin calcium
A Study to Evaluate the Safety and Bioequivalence of Mupirocin Calcium Cream, 2% and Bactroban® Cream and Compare Both to a Vehicle in Treatment of Secondarily Infected Traumatic Skin Lesions.
Status: Completed Condition: Secondarily Infected Traumatic Skin Lesions
Mupirocin Ointment to Eliminate Nasal Carriage of Staphylococcus Aureus in HIV Infection
Status: Completed Condition: Nasal Colonization With Staphylococcus Aureus; HIV Infections
Prevention of Surgical Site Infections: Effectiveness of Nasal Povidone-Iodine and Nasal Mupirocin
Status: Completed Condition: Surgical Site Infection
Efficacy Study of Mupirocin on Infection After Coronary Artery Bypass Grafting
Status: Completed Condition: Surgical Site Infections
Safety and Efficacy of Intranasal and Topical Mupirocin in Eradicating Colonization With Staphylococcus Aureus (SA) in Critically Ill Infants - a Phase 2, Multi-Center, Open Label, Randomized Trial
Status: Recruiting Condition: Staphylococcal Infection
Preventing Staphylococcal (Staph) Infection
Status: Completed Condition: Staphylococcal Infections
Topical Gentamicin Cream Versus Alternating Gentamicin and Mupirocin Cream in Peritoneal Dialysis
Status: Not yet recruiting Condition: Rate of Exit Site Infection; Rate of Atypical Mycobacterial Infection; Rate of Peritoneal Dialysis
Prophylaxis With Intranasal Mupirocin for Prevention of S. Aureus Infections
Status: Completed Condition: Cross Infection; Staphylococcal Infections
Impact of Mupirocin Decolonization on the Nasal Microbiome
Status: Recruiting Condition: Nasal Colonization With Staph Aureus
Use of Ointments in Prevention of Catheter Related Infections in PD
Status: Active, not recruiting Condition: Peritoneal Dialysis
Courtesy of ClinicalTrials.org
See more clinical trials for this drug
|Applicant||Tradename||Generic Name||Dosage||NDA||Approval Date||Type||RLD||Patent No.||Patent Expiration||Product||Substance||Delist Req.||Patented / Exclusive Use|
|OINTMENT;NASAL||050703||Sep 18, 1995||RX||Yes||5,569,672||<disabled>||TREATMENT OF BACTERIAL INFECTIONS IN THE NASAL PASSAGE OF ADULT PATIENTS AND HEALTH CARE WORKERS WITH METHICILLIN RESISTANT S. AUREUS|
|CREAM;TOPICAL||201587||Jan 24, 2013||RX||No||<disabled>|
|CREAM;TOPICAL||050746||Dec 11, 1997||RX||Yes||6,025,389||<disabled>||Y||TREATMENT OF SECONDARILY INFECTED TRAUMATIC SKIN LESIONS DUE TO S. AUREUS AND S. PYOGENES|
|CREAM;TOPICAL||050746||Dec 11, 1997||RX||Yes||5,569,672||<disabled>||TREATMENT OF BACTERIAL INFECTIONS IN THE NASAL PASSAGE OF ADULT PATIENTS AND HEALTH CARE WORKERS WITH METHICILLIN RESISTANT S. AUREUS|
|This preview shows a limited data set|
Complete access is available with a Subscription
Export unavailable in trial.
Subscribe for complete access.
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors.
Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided information. There is no warranty that the information contained herein is error free. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.
Copyright © 2002-2014 thinkBiotech LLC. ISSN: 2162-2639